Back to mobile site

Citi Maintains 'Buy' Rating on Amgen (AMGN), Adds Stock to Top Picks Live List

November 21, 2008 9:47 AM EST Send to a Friend
Citi maintains a 'Buy' rating on Amgen Inc (Nasdaq: AMGN), adds stock to Top Picks Live list. Price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login